R21/Matrix-M™ Malaria Vaccine with Novavax’s Adjuvant Receives WHO Recommendation | NVAX Message Board Posts


NVAX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  213738 of 220168  at  10/3/2023 6:52:17 AM  by

PT22


 In response to msg 213730 by  Bradyman68
view thread

Re: R21/Matrix-M™ Malaria Vaccine with Novavax’s Adjuvant Receives WHO Recommendation

Usually with recommendations or approvals - NoVax stock price tanks. The reason: Just like with the Corona pandemic of which NoVax missed basically the entire pandemic, the embarrassment NoVax company does not know how to execute/commercialize sales in an expeditious way & Wall Street knows this long ago by having observed NoVax’ actual commercialization performance the last 3 years.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...